Anna Komosa
Overview
Explore the profile of Anna Komosa including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
39
Citations
203
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Poniedzialek B, Perek B, Proch A, Komosa A, Niedzielski P, Buczkowski P, et al.
Sci Rep
. 2025 Jan;
15(1):1233.
PMID: 39775052
Aortic stenosis (AS) is a leading cause of surgical intervention in adults with acquired heart disease, driven by an aging population and advancements in diagnostic and treatment approaches. This study...
2.
Urbanowicz T, Hanc A, Olasinska-Wisniewska A, Komosa A, Filipiak K, Radziemski A, et al.
Rev Cardiovasc Med
. 2024 Jul;
24(12):358.
PMID: 39077068
Background: Coronary artery atherosclerosis development and progression are related to generic, clinical, and lifestyle factors combined with inflammatory activation. The relationship between trace element concentration and morbidity is under investigation...
3.
Lipski D, Radziemski A, Wasiliew S, Wyrwa M, Szczepaniak-Chichel L, Stryczynski L, et al.
BMC Infect Dis
. 2024 Jul;
24(1):685.
PMID: 38982355
Background: Coronavirus disease (COVID-19) may lead to serious complications and increased mortality. The outcomes of patients who survive the early disease period are burdened with persistent long-term symptoms and increased...
4.
Glowka A, Kowalowka M, Burchardt P, Komosa A, Kruszyna L, Andrusiewicz M, et al.
Nutrients
. 2024 Jun;
16(12).
PMID: 38931221
Cardiovascular diseases (CVD) are the leading cause of death worldwide, influenced by the interaction of factors, including age, sex, genetic conditions, overweight/obesity, hypertension, an abnormal lipid profile, vitamin deficiencies, diabetes,...
5.
Urbanowicz T, Olasinska-Wisniewska A, Michalak M, Komosa A, Filipiak K, Uruski P, et al.
Cardiol J
. 2023 Dec;
31(5):722-730.
PMID: 38149491
Background: The coronary artery disease (CAD) remains the leading cause of morbidity that is characterized by broad spectrum of symptoms. Up to 30% of performed angiographies reveal normal coronary arteries....
6.
Urbanowicz T, Olasinska-Wisniewska A, Grodecki K, Fryska Z, Komosa A, Uruski P, et al.
Kardiol Pol
. 2023 Sep;
81(7-8):769-771.
PMID: 37711047
No abstract available.
7.
Urbanowicz T, Michalak M, Komosa A, Olasinska-Wisniewska A, Filipiak K, Tykarski A, et al.
Cardiol J
. 2023 Jun;
31(4):583-595.
PMID: 37314004
Background: Currently, atherosclerotic cardiovascular disease is the major cause of mortality world-wide. Inflammatory processes are postulated to be a major driving force for coronary plaque initiation and progression and can...
8.
Urbanowicz T, Michalak M, Marzec E, Komosa A, Filipiak K, Olasinska-Wisniewska A, et al.
Int J Environ Res Public Health
. 2023 Feb;
20(3).
PMID: 36768108
Background: The electrical properties of cells and tissues in relation to energy exposure have been investigated, presenting their resistance and capacitance characteristics. The dielectric response to radiofrequency fields exhibits polarization...
9.
Lesiak M, Komosa A
Postepy Kardiol Interwencyjnej
. 2022 Feb;
17(4):340-343.
PMID: 35126547
Dual antiplatelet therapy (DAPT) is a foundation of successful coronary artery disease management. DAPT is recommended according to ESC guidelines for 6 months following elective percutaneous coronary intervention and for...
10.
Perek B, Rzymski P, Komosa A, Olasinska-Wisniewska A, Puslecki M, Jemielity M, et al.
Cardiol J
. 2021 Nov;
PMID: 34787889
Background: Excessive metabolic excitation of platelets after cardiac procedures may be related to some adverse events but assessment of their metabolic activity is not routine. The purpose of this study...